ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

ACIU AC Immune SA

0,00
0,00 (0,00%)

Période:

Mode Dessin:

Volume 0
Prix Achat
Prix Vente
Actualités -
Maximum Haut

Bas
2,20

Sur 52 semaines

Haut
5,14

Minimum Bas
Nom Action Symbole Action Marché Type
AC Immune SA ACIU NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% -
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
Transactions Totales Volume échangé Volume en moyenne Sur 52 semaines
0 0 - 2,20 - 5,14
Dernière Transaction Type Quantités échangées Prix transaction Devise
- 0 USD

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
393,82M 99,20M - 14,8M -54,23M -0,55 -
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action AC Immune

Date Heure Source Titre
21/5/202414:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/5/202420:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
13/5/202412:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/5/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/2/202422:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
22/1/202413:53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202422:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202414:10GlobeNewswire Inc.AC Immune Progress Update on Phase 2 Active Immunotherapy..
28/12/202322:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
19/12/202314:53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/12/202323:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
15/12/202322:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securities

Forum Action AC Immune

Aucune Discussion TrouvéeAjouter une Discussion

Historiques AC Immune SA

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine4,064,413,804,05287 4140,000,00%
1 mois4,314,97823,804,49347 5330,000,00%
3 mois2,744,97822,253,40917 4340,000,00%
6 mois4,945,142,253,42506 0020,000,00%
1 an3,095,142,203,38318 9860,000,00%
3 ans8,4512,611,685,33434 2490,000,00%
5 ans5,4214,891,686,16429 0030,000,00%